Pharmacists can play an instrumental role in the administration of psychotropic long-acting injectable (LAI) medications (antipsychotics, naltrexone, buprenorphine) but may lack the training needed to perform this important service. This mutli-faceted, on demand educational activity aims to reduce barriers and increase patient access to LAIs through a universal training program that includes, but is not limited to, appropriate patient selection, LAI preparation and administration techniques, and insights into methods to engage a patient population with serious mental illness.
This ACPE approved educational activity includes 5 hours of on demand recorded webinars on psychotropic LAI patient selection, pharmacology, dosing, preparation/administration/storage, key adverse effects and mitigation strategies, and building an LAI practice. Videos on LAI administration are incorporated into the curriculum to enhance learning and real-life application.
Introduction to Long-Acting Injectables and Patient Selection
Samantha Catanzano, PharmD, BCPP
Clinical Assistant Professor
The University of Texas at Austin College of Pharmacy
Austin, TX
Antipsychotic Long-Acting Injectable Pharmacology and Dosing
Megan Ehret, PharmD, MS, BCPP
Professor
University of Maryland
Baltimore, MD
Antipsychotic Long-Acting Injectable Preparation, Administration, and Storage
Christine Rarrick, MBA, PharmD, BCPP, BCPS
Clinical Pharmacy Specialist
MUSC
Charleston, SC
Antipsychotic Long-Acting Injectable Adverse Effects, Mitigation Strategies, and Monitoring
Substance Use Disorder Long-Acting Injectables: Naltrexone and Buprenorphine
Building a Long-Acting Injectable Practice
| Title | Hours | Register |
|---|---|---|
| Introduction to Long-Acting Injectable Antipsychotics and Patient Selection ACPE Pre-registration is available, and the course will launch May 15, 2023! This webinar reviews the signs, symptoms, and diagnostic ...[more] | 0.5 | FREE! |
| Antipsychotic Long-Acting Injectable Pharmacology and Dosing ACPE Pre-registration is available, and the course will launch May 15, 2023! This webinar summarizes the approved indications, ...[more] | 1 | FREE! |
| Antipsychotic Long-Acting Injectable Preparation, Administration, and Storage ACPE Pre-registration is available, and the course will launch May 15, 2023! This webinar highlights key considerations for ...[more] | 1 | FREE! |
| Antipsychotic Long-Acting Injectable Adverse Effects, Mitigation Strategies, and Monitoring ACPE Pre-registration is available, and the course will launch May 15, 2023! This webinar reviews the contraindications, ...[more] | 0.75 | FREE! |
| Substance Use Disorder Long-Acting Injectables: Naltrexone and Buprenorphine ACPE Pre-registration is available, and the course will launch May 15, 2023! This webinar focuses on important factors related to use of ...[more] | 0.75 | FREE! |
| Building a Long-Acting Injectable Practice ACPE Pre-registration is available, and the course will launch May 15, 2023! The content in this webinar assists with building and ...[more] | 1 | FREE! |